Best Oncology in Spain

Dr. Antonio Cubillo emerges as a prominent figure in the realm of oncology, bringing over two decades of expertise to the forefront. Currently serving as the head of the Center of Medical Oncology at the Centro Integral Oncológico Clara Campal and an associate professor of oncology at the University CEU San Pablo, Madrid, Dr. Cubillo stands as a renowned oncologist with a specialization in sarcoma, gastrointestinal, and genitourinary tumors. His extensive experience is underscored by his role as a specialist at the MD Anderson International Hospital in Madrid, where he focuses on solid tumors and serves as the coordinator of the oncology emergency service. Dr. Cubillo's educational journey includes earning his medical degree from the Universidad Autónoma de Madrid in Spain in 1994. Complementing his medical qualifications, he holds a master's degree in Palliative and Supportive Care and has undergone postgraduate training in Medical Oncology, obtaining certification in the field. Actively contributing to the advancement of oncological knowledge, Dr. Cubillo is associated with clinical trials at Clinica CONIM in Madrid, Spain, showcasing his commitment to cutting-edge research and patient care. His memberships in esteemed organizations such as the Spanish Society of Medical Oncology, the Treatment Group of GI Tumors, and the Spanish group of Sarcoma research further attest to his dedication to collaborative and comprehensive oncological care. Dr. Cubillo's prolific career is enriched by his involvement as an investigator in over 100 clinical trials, numerous scientific articles, book chapters, and abstracts, solidifying his position as a respected authority in the field of oncology.

Dr. Blanca Lopez Ibor stands as a distinguished figure in the field of Oncology and Hematology Oncology, contributing over 35 years of expertise to the medical landscape. Currently serving as the director of the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital in Madrid, Spain, Dr. Lopez Ibor specializes in the comprehensive care of children and adolescents facing various challenging conditions, including Ewing's Sarcoma, Leiomyosarcoma, Sarcoma, Leucosis, Multiple Myeloma, Leukemia, Non-Hodgkin's Lymphoma, and Lymphoma. Her stellar reputation is underscored by a perfect 5 out of 5 rating from those who have sought her expertise. Educationally, Dr. Lopez Ibor earned her degree in Medicine from the esteemed Complutense University of Madrid, where she completed her residency in Pediatrics. Further enhancing her specialization, she pursued Pediatric Hematology and Oncology at the University of Maryland in the United States, culminating in the title of Doctor of Medicine from the University of Barcelona. Dr. Lopez Ibor's impressive career includes leadership roles such as the head of the Pediatric Hematology and Oncology Unit at Hospital Montepríncipe since 2006 and prior leadership at Hospital Universitario Clínica San Rafael. In addition to her impactful clinical contributions, Dr. Lopez Ibor is an active member of prominent national and international societies, including ASH (American Society of Hematology), ASPHO (American Society of Pediatric Hematology/Oncology), SIOP (International Society of Paediatric Oncology), and AEP (Spanish Association of Pediatrics). Her commitment to advancing knowledge is evident through her authorship of numerous publications, both at the national and international levels. Dr. Blanca Lopez Ibor continues to be a beacon of expertise and compassion in the realm of pediatric hematology and oncology.

Dr. Carme Ares leads a distinguished career spanning over 30 years. Holding a Medical Degree from the Autonomous University of Barcelona since 1991, Dr. Ares further solidified her expertise by earning a Ph.D. in 2018. Notably, she enriched her skills during a tenure as a Senior Consultant at the esteemed Proton Therapy Center at Massachusetts Hospital in Boston, USA, in 2006. Following this, she contributed to the field as a Senior Radio Oncologist at the Paul Scherrer Institute in Switzerland. Since 2018, Dr. Ares has held the position of Senior Specialist in Radiooncology at MAASTRO-ZON-PTC Clinic in the Netherlands. Specializing in Oncology, Dr. Ares receives a majority of referrals for the treatment of conditions such as Glioblastoma, Meningioma, Retinoblastoma, Kidney Cancer, Prostate Cancer, Liver Cancer, and Lung Cancer. Her commitment to personalized patient care is reflected in the provision of free consultations, personalized treatment plans, and the assurance of priority appointments. Dr. Ares' dedication to advancing medical knowledge is evident through her authorship of various books and presentations at national and international conferences. Experience excellence in cancer care under the guidance of Dr. Carme Ares at the forefront of the Quironsalud Proton Therapy Center.

Dr. Eduardo Castañón Álvarez, a highly regarded oncology specialist at Clínica Universidad de Navarra in Pamplona, Spain, brings a wealth of experience and unwavering clinical expertise to his practice. With six years in the field, Dr. Castañón Álvarez is recognized for his proficiency in diagnosing neoplasms and providing comprehensive treatment for various oncological lesions affecting the body. Notably, he holds ESMO MORA certification, reflecting his commitment to the highest standards of oncological care. Dr. Castañón Álvarez's educational journey includes a bachelor's degree in medicine from Navarra University in 2009, followed by specialization in oncology at the same institution until 2015. During this period, he earned the title of Doctor of Medicine. His dedication to continuous learning is evident through his internship at the Gustave Roussy Institute, where he focused on trials conducted by the DITEP group from 2015 to 2017. Additionally, he holds a master's degree in biostatistics and molecular oncology. In his professional career, Dr. Castañón Álvarez has emerged as a key figure in the oncology sector at Navarra Hospital, maintaining his association with the institute since 2015. He also holds prominent roles as a leading professor at Navarra University and the MIR academy. Actively engaged in the academic and research community, he is associated with prestigious societies and organizations, including the Spanish (SEOM), American (ASCO), and European (ESMO) cancer societies. Furthermore, he contributes to cancer research on an international scale as a member of the American (AACR) and European (EORTC) cancer research organizations. Dr. Eduardo Castañón Álvarez's notable achievements extend beyond his clinical practice, with participation in over 50 communications at global conferences and co-authorship of eight books aimed at students specializing in the field. His research contributions include the publication of 38 articles in globally recognized journals, showcasing his commitment to advancing oncological knowledge and treatment strategies.

Dr. Javier Cortes Castan is a distinguished oncologist specializing in breast malignancy and gynecological tumors. With over 20 years of experience, he has established himself as a leading figure in the field, renowned for his expertise and dedication to advancing cancer research. Dr. Cortes Castan's primary focus lies in pioneering research aimed at revolutionizing the treatment of breast cancer, with a vision of significantly improving outcomes for patients in the near future. Educated at the Autonomous University and the University of Navarra, Dr. Cortes Castan underwent specialized training in oncology, during which he actively contributed to the Sector of Cancer. Currently, he serves as a key figure in the Medical Oncology sector at the Vall d'Hebron Hospital in Barcelona and leads the breast malignancy project at the IOB Cancer center. Additionally, he holds the position of Chief of the Breast Oncology unit at the prestigious Ruber International Hospital in Madrid. Dr. Cortes Castan's remarkable contributions to oncology include leading roles in the development of cutting-edge medications and significant involvement in numerous cancer research projects worldwide. He is a member of various international Cancer Societies and the Scientific society ESMO, demonstrating his commitment to advancing the field of oncology through collaboration and innovation.

Dr. Joan Carles Galceran, a highly esteemed medical oncologist, holds a prominent position at the Quironsalud Teknon Medical Center in Barcelona, Spain, where he specializes in oncology with a notable four decades of experience. Currently serving as the Chief of the 'central nervous system, genitourinary, sarcoma, and tumors of unspecified origin' division at Vall'd Hebron University Hospital, Dr. Galceran has dedicated more than 30 years to the field of oncology. Dr. Galceran's educational journey is marked by significant achievements, beginning with his graduation in medicine and surgery from the University of Barcelona in 1987. He furthered his academic pursuits, obtaining his doctorate from the Autonomous University of Barcelona in 1992, followed by a specialization certificate in medical oncology from 1994 to 1996. Dr. Galceran initiated his professional career during his Ph.D., undergoing residency in medical oncology at German Trias I Pujol University Hospital, Badalona, from 1988 to 1990. His extensive career includes roles at Terrassa Hospital and Hospital del Mar, Barcelona, before assuming the pivotal position as the head of the department at Vall'd Hebron University Hospital in 2008. Simultaneously, Dr. Galceran has been contributing to academia as an adjunct professor at the Autonomous University, Barcelona, since 1995. As an active member of prestigious associations such as the Spanish Community for Treatment of Genitourinary Cancer, Spanish Association of Head and Neck Tumors, German Sarcoma Research Committee, and the European Community for Medical Oncology, Dr. Joan Carles Galceran exemplifies his commitment to advancing oncological care. His contributions extend beyond clinical practice, with over 70 published articles and approximately 100 conference papers on genitourinary cancer and sarcoma, solidifying his reputation as a leading figure in the field of oncology.

Dr. Lisardo Ugidos De La Varga is a highly accomplished oncologist contributing significantly to the field of medical oncology in Madrid, Spain. With extensive experience and a profound commitment to advancing cancer treatment, Dr. Ugidos is currently serving as the Director of Clinical Research at the Vithas Oncology Institute (IOV) in Madrid. His leadership at IOV encompasses three prominent medical centers: Vithas Madrid Arturo Soria University Hospitals, Vithas Madrid La Milagrosa, and Vithas Madrid Aravaca, reinforcing the institute's healthcare strategy focused on specialized institutes. Dr. Ugidos specializes in various aspects of oncology, including lung cancer, head and neck cancer, immunotherapy, molecular targets, oncogeriatrics, and clinical trials. His dedication extends beyond clinical practice, as he also holds the position of President of TOMAKAKU, a multidisciplinary collaborative group on head and neck cancer comprising specialists from the Community of Madrid and Castilla-La Mancha. Dr. Ugidos' remarkable career involves significant contributions to translational research, evidenced by his fellowship in translational oncology at the Methodist Hospital in Houston, USA. Having participated in numerous clinical trials related to immunotherapy and targeted therapies, Dr. Ugidos stands as a key figure in advancing treatment modalities. His comprehensive approach to patient care, including optimizing screening for elderly patients and enhancing their quality of life during antitumor treatments, reflects his commitment to improving cancer care. Born in León in 1977, Dr. Lisardo Ugidos De La Varga graduated in Medicine from the Autonomous University of Madrid in 2001, specializing in Medical Oncology at the Ramón y Cajal Hospital in Madrid between 2002 and 2006. His journey encompasses diverse medical roles, with a focus on delivering exceptional oncological care and pioneering research in the quest for innovative cancer therapies.

Dr. Salvador Martin Algarra, a distinguished Medical Oncologist at Clínica Universidad de Navarra, also holds the position of Professor of Oncology at the Medical School of the University of Navarra in Pamplona, Spain. With an illustrious career, he obtained his Doctorate in Medicine and Surgery from the University of Navarra in 1985, following which he specialized in Medical Oncology in 1991. Dr. Martin Algarra furthered his expertise through a clinical fellowship in Oncology/Hematology at the University of Nebraska Medical Center in Omaha, USA. Dr. Martin Algarra has played pivotal roles in the medical field, serving as a member of the Directive Board of Clínica Universidad de Navarra and holding positions such as President of its Educational Board, Director of the Department of Oncology, and co-director of the Cell Therapy Area at the University of Navarra. His current focus lies in the therapeutic development of immunotherapy and targeted therapies, particularly in melanoma, sarcoma, and rare tumors. Dr. Martin Algarra is a founding member and the current President of the Spanish Melanoma Group (GEM). Engaged in extensive research, he has participated in 48 research projects and acted as the Leading Investigator for 43 of them, with a primary interest in melanoma and sarcomas of unknown origin. As an educator, Dr. Martin Algarra imparts his knowledge through teaching responsibilities at the University of Navarra Faculty of Medicine, contributing significantly to undergraduate and graduate education in Medical Oncology. His prolific research contributions include 90 publications in indexed journals, 29 of which are in the first tertile, and active participation in numerous conferences and scientific committees. Dr. Martin Algarra's expertise encompasses a wide range of oncological areas, making him a key figure in advancing cancer research and treatment.

Dr. Teresa Acuña Gutierrez, a distinguished oncologist based in Mallorca, Spain, has garnered extensive experience and recognition in the field of oncology. Graduating with distinction in medicine from the University of San Martin de Porres in 1998, Dr. Teresa subsequently specialized in oncology, completing her training in 2005 at the University Federico Villareal. Further enriching her expertise, she pursued MIR training in Germany and conducted research at University Hospital Son Espases. Throughout her career, Dr. Teresa has demonstrated a commitment to patient care and medical research. She commenced her professional journey by providing occupational services for chronic pain management, followed by a pivotal role in the urological oncology unit at Son Espases. Notably, she performed nephrectomy procedures and contributed to critical patient care. In 2013, Dr. Teresa joined Clinica Rotger, where she currently serves as a senior physician in the oncology unit. Her dedication to advancing oncological knowledge is evident in her 32 research articles on intensive care therapy and active participation in international conferences and seminars. Dr. Teresa Acuña is a permanent member of ESMO, part of the Spanish Association of Oncology, and holds memberships in esteemed oncological societies.

Meet Dr. Victoria Becerra Castro, an esteemed specialist in pediatric neurology, based at Sant Joan de Déu Hospital in Barcelona, Spain. With a decade of experience, Dr. Becerra Castro has dedicated her career to the intricate realms of neurology and neurosurgery, earning a stellar reputation among her peers and patients alike. Her expertise extends to the surgical treatment of brain and spinal tumors, showcasing a profound commitment to addressing complex neurological conditions. Dr. Becerra Castro's academic journey is marked by distinction, having graduated from the Universidad de Extremadura in 2012. Subsequently, from 2013 to 2018, she pursued residential education in neurosurgery at the prestigious Universidad de Navarra Clinic. In 2019, she further solidified her knowledge and skills by obtaining a Ph.D. from the same esteemed institution. Since 2018, Dr. Victoria Becerra Castro has been an integral part of the neurosurgery team at Sant Joan de Déu-Barcelona Hospital, contributing significantly to the advancement of pediatric neurosurgical care. Her noteworthy publications in her field, including contributions to the NIH platform, underscore her commitment to sharing knowledge and advancements in pediatric neurology. Driven by a passion for improving the lives of her young patients, Dr. Becerra Castro stands as a dedicated professional in the dynamic intersection of pediatric neurology and neurosurgery.